The NCI PREVENT Cancer Preclinical Drug Development Program – NCI Division of Cancer Prevention
NCI Division of Cancer Prevention shared on LinkedIn:
“Application deadline Monday!
Are you someone actively looking for resources to bolster your research on cancer preventive agent development? The NCI PREVENT Cancer Preclinical Drug Development Program \(PREVENT\) is a peer-reviewed program that supports the preclinical development of innovative interventions and predictive biomarkers for cancer prevention and interception towards clinical applications in high-risk populations.
All interested researchers from academia, industry, non-profits, and government with innovative ideas in precision cancer prevention are encouraged to apply.
Deadline: Monday, July 8, 2024.
For more information on Program support, types of supported projects, and the application visit here.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023